Pharmaceutical Preparations · DE · CIK 1683553
SPRUCE BIOSCIENCES, INC. develops and commercializes novel therapies for serious neurological disorders
Comparable business profile · signals at a glance
In the 90 days to Oct 6, 2025: 1 insider bought $9K · 1 sold $10K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2025 | Parkman Healthcare Partners LlcTenPercentOwner | Buy | 256 | $17.91 | $5K |
| Oct 6, 2025 | Parkman Healthcare Partners LlcTenPercentOwner | Buy | 256 | $17.91 | $5K |
| Oct 6, 2025 | Parkman Healthcare Partners LlcTenPercentOwner | Sell | 232 | $19.33 | $4K |
| Oct 6, 2025 | Parkman Healthcare Partners LlcTenPercentOwner | Sell | 232 | $19.33 | $4K |
| Oct 6, 2025 | Parkman Healthcare Partners LlcTenPercentOwner | Sell | 25 | $17.46 | $437 |
| Oct 6, 2025 | Parkman Healthcare Partners LlcTenPercentOwner | Sell | 25 | $17.46 | $437 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.